Drug Enforcement Administration November 2017 – Federal Register Recent Federal Regulation Documents

First Choice Surgery Center of Baton Rouge, L.L.C.; Decision and Order
Document Number: 2017-25288
Type: Notice
Date: 2017-11-22
Agency: Drug Enforcement Administration, Department of Justice
Arnold E. Feldman, M.D.; Decision and Order
Document Number: 2017-25287
Type: Notice
Date: 2017-11-22
Agency: Drug Enforcement Administration, Department of Justice
Linda M. Shuck, D.O.; Decision and Order
Document Number: 2017-25286
Type: Notice
Date: 2017-11-22
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2017-25285
Type: Notice
Date: 2017-11-22
Agency: Drug Enforcement Administration, Department of Justice
Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration as bulk manufacturers of various classes of schedule I and II controlled substances.
Importer of Controlled Substances Registration
Document Number: 2017-25284
Type: Notice
Date: 2017-11-22
Agency: Drug Enforcement Administration, Department of Justice
Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration as importers of various classes of schedule I or II controlled substances.
Schedules of Controlled Substances: Placement of FDA-Approved Products of Oral Solutions Containing Dronabinol [(-)-delta-9-trans-tetrahydrocannabinol (delta-9-THC)] in Schedule II
Document Number: 2017-25275
Type: Rule
Date: 2017-11-22
Agency: Drug Enforcement Administration, Department of Justice
This final rule adopts without changes an interim final rule with request for comments published in the Federal Register on March 23, 2017. On July 1, 2016, the U.S. Food and Drug Administration (FDA) approved a new drug application for Syndros, a drug product consisting of dronabinol [(-)-delta-9-trans-tetrahydrocannabinol (delta-9-THC)] oral solution. The Drug Enforcement Administration (DEA) maintains FDA- approved products of oral solutions containing dronabinol in schedule II of the Controlled Substances Act.
Schedules of Controlled Substances: Temporary Placement of Cyclopropyl Fentanyl into Schedule I
Document Number: 2017-25077
Type: Proposed Rule
Date: 2017-11-21
Agency: Drug Enforcement Administration, Department of Justice
The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule the synthetic opioid, N-(1-phenethylpiperidin-4-yl)-N- phenylcyclopropanecarboxamide (cyclopropyl fentanyl), into Schedule I. This action is based on a finding by the Administrator that the placement of this synthetic opioid into Schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. When it is issued, the temporary scheduling order will impose the administrative, civil, and criminal sanctions and regulatory controls applicable to Schedule I controlled substances under the Controlled Substances Act on the manufacture, distribution, reverse distribution, possession, importation, exportation, research, and conduct of instructional activities, and chemical analysis of this synthetic opioid.
Importer of Controlled Substances Application: Anderson Brecon, Inc.
Document Number: 2017-24674
Type: Notice
Date: 2017-11-15
Agency: Drug Enforcement Administration, Department of Justice
Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2018
Document Number: 2017-24306
Type: Notice
Date: 2017-11-08
Agency: Drug Enforcement Administration, Department of Justice
This final order establishes the initial 2018 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.
Bulk Manufacturer of Controlled Substances Application: Cambrex Charles City
Document Number: 2017-24201
Type: Notice
Date: 2017-11-07
Agency: Drug Enforcement Administration, Department of Justice
ChipRX, L.L.C., d/b/a City Center Pharmacy; Decision and Order
Document Number: 2017-24093
Type: Notice
Date: 2017-11-06
Agency: Drug Enforcement Administration, Department of Justice
``The pt. denied taking anything other than Percocet several days prior to admission.'')
Bulk Manufacturer of Controlled Substances Application: Cerilliant Corporation
Document Number: 2017-24090
Type: Notice
Date: 2017-11-06
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Rhodes Technologies
Document Number: 2017-24012
Type: Notice
Date: 2017-11-03
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Temporary Placement of FUB-AMB Into Schedule I
Document Number: 2017-24010
Type: Rule
Date: 2017-11-03
Agency: Drug Enforcement Administration, Department of Justice
The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to schedule the synthetic cannabinoid, methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3- methylbutanoate [FUB-AMB, MMB-FUBINACA, AMB-FUBINACA], and its optical, positional, and geometric isomers, salts, and salts of isomers into schedule I. This action is based on a finding by the Administrator that the placement of this synthetic cannabinoid into schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle, FUB-AMB.
Final Adjusted Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2017
Document Number: 2017-24009
Type: Notice
Date: 2017-11-03
Agency: Drug Enforcement Administration, Department of Justice
This final order establishes the final adjusted 2017 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.